Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myeloma

  1. De Queiroz Crusoe, E.
  2. Maiso, P.
  3. Fernandez-Lazaro, D.
  4. San-Segundo, L.
  5. Garayoa, M.
  6. Garcia-Gomez, A.
  7. Gutierrez, N.C.
  8. Delgado, M.
  9. Colado, E.
  10. Martin-Sanchez, J.
  11. Lee, F.Y.
  12. Ocio, E.M.
Journal:
Annals of Hematology

ISSN: 0939-5555 1432-0584

Year of publication: 2012

Volume: 91

Issue: 2

Pages: 257-269

Type: Article

DOI: 10.1007/S00277-011-1287-Z GOOGLE SCHOLAR

Sustainable development goals